DGCI approves marketplace authorisation for Serum Institute’s Covovax as heterologous booster dose
The Drug Controller Basic of India (DCGI) has licensed marketplace authorisation to Serum Institute of India’s Covid-19 vaccine Covovax as a heterologous booster dose for adults, reputable assets informed PTI on Monday. Covovax can be utilized as a heterologous booster dose for adults who’ve been administered two doses of Covishield or Covaxin, they stated. The … Read more